SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Pat…
작성자 채식영양
작성일 25-01-01 00:00
조회 0
댓글 0
본문
PJ. Solinsky, A. Holstege and G. Burnie (2025). SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors. The Annals of pharmacotherapy, 59(7), 671-673. https://doi.org/10.1177/10600280241294060
댓글목록 0
등록된 댓글이 없습니다.
